I. A. Yatskov
← Back to Crimea State Medical University named after S. I. Georgievsky
Crimea State Medical University named after S. I. Georgievsky
I. A. Yatskov works in COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, SARS-CoV-2 and COVID-19 Research, Adipokines, Inflammation, and Metabolic Diseases, Asthma and respiratory diseases. Recorded institutional associations include Crimea State Medical University named after S. I. Georgievsky, V.I. Vernadsky Crimean Federal University.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Lipopolysaccharide and ARDS caused by new coronavirus infection: hypotheses and facts
2022 · 16 citationsMetabolic endotoxemia: possible causes and consequences
2021 · 8 citationsCathepsin G in Patients with SARS-Cov-2 Infection of Various Degrees of Severity
2022 · 6 citationsEndocrine disorders in the background of COVID-19 and postcovid syndrome
2022 · 5 citationsLow-grade systemic inflammation in patients with long COVID: The role of imbalance of endotoxin-releasing systems and vasoconstrictor markers
2024 · 5 citationsLipopolysaccharide-binding protein and presepsin in patients with SARS-CoV-2 viral lung disease in the Republic of Crimea
2022 · 4 citationsLow-grade inflammation in the post-COVID period as a strategic goal of treatment and rehabilitation
2024 · 4 citationsProspects for the use of polyphenols in patients with bronchial asthma and obesity
2024 · 3 citationsTSH-рroducing pituitary microadenoma: diagnostic problems in the debut of the disease
2022 · 2 citationsFeatures of the frequency of occurrence of T-330G IL2 gene polymorphism in patients with COVID-19
2023 · 2 citationsInfluence of health resort treatment on the level of systemic inflammation in patients after new coronavirus infection
2023 · 2 citationsRole of сathepsin G in pathogenesis of chronic obstructive lung disease: possible ways of regulation
2020 · 1 citationsExpression and polymorphism of lTLR4 receptors in pathogenesis of chronic obstructive pulmonary disease: a modern view
2021 · 1 citationsInfluence of antibiotic therapy on indicators of endotoxinemia and systemic inflammation in acute SARS-CoV-2 lung damage
2022 · 1 citationsThe Impact of Post COVID Rehabilitation on the Level of Systemic Inflammation in Patients with Post COVID Syndrome
2023 · 1 citationsSome Features of Laboratory Parameters in Patients with SARS-CoV-2 with Underlying Overweight and Obesity
2023 · 1 citationsRole of Toll-like receptor gene polymorphism in pathogenesis of new coronavirus infection
2023 · 1 citationsEffect of Rebamipide on Low-grade Inflammation in Post COVID-19 Syndrome Patients
2024 · 1 citationsIMPAIRED REGULATION OF RESPONSES TO ENDOTOXIN IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
2024 · 1 citationsRole of lipopolysaccharide in genesis of microvascular complications in type 1 diabetes mellitus
2023 · 1 citationsArg25Pro polymorphism of TGFβ gene as a factor in differentiated approach to prophylaxis in patients with type 1 diabetes mellitus
2024 · 1 citationsEffect of IL-2 T-330G polymorphism on markers of systemic inflammation, intestinal permeability and vascular regulation in post-COVID patients
2024 · 1 citationsP096 LIPOPOLYSACCHARIDE-BINDING SYSTEMS IN PATIENTS WITH SARS-COV-19 INFECTION HAVING VARIOUS DEGREES OF SEVERITY
2021 · 0 citationsOutpatient antibiotic therapy leads to endotoxemia markers elevation in acute SARS-CoV-2 lung damage
2022 · 0 citationsPOLYMORPHISM OF THE TNFAIP3 GENE (T380G) AND EXPRESSION OF TNFAIP3 IN PATIENTS WITH BRONCHIAL ASTHMA
2021 · 0 citations
